Instead of a central catheter, the study suggests using a peripheral catheter for continuous intravenous infusion of hypertonic saline. This would cut down on unnecessary use of central catheters, which would lower costs and could lead to fewer infections.
Researchers conducted a retrospective study at two academic medical centers of data on patients treated with continuous intravenous infusion of the solution. Of the 213 patients who had the solution administered peripherally, 15 had infusion-related reactions. Most (73.7 percent) received their entire treatment peripherally.
“Current recommendations that a central catheter is required for continuous intravenous infusion of 3 percent sodium chloride solution should be re-evaluated,” the study concludes. “Only a few patients who had peripheral infusions had infusion-related reactions.”
More articles on patient safety:
769 hospitals see Medicare payments cut over high HAC rates: 7 things to know
AACN issues practice alerts on CAUTIs, VTE and delirium
Manuka honey could boost CAUTI prevention
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
